Skip to content

Advertisement

Cell & Bioscience

Research
Open Access

Molecular characterization of HIV-1 genome in fission yeast Schizosaccharomyces pombe

†Contributed equally
Cell & Bioscience20155:47

https://doi.org/10.1186/s13578-015-0037-7

©  Nkeze et al. 2015

Received: 9 June 2015

Accepted: 27 July 2015

Published: 25 August 2015

Abstract

Background

The human immunodeficiency virus type 1 (HIV-1) genome (~9 kb RNA) is flanked by two long terminal repeats (LTR) promoter regions with nine open reading frames, which encode Gag, Pol and Env polyproteins, four accessory proteins (Vpu, Vif, Vpr, Nef) and two regulatory proteins (Rev, Tat). In this study, we carried out a genome-wide and functional analysis of the HIV-1 genome in fission yeast (Schizosaccharomyces pombe).

Results

Each one of the HIV-1 genes was cloned and expressed individually in fission yeast. Subcellular localization of each viral protein was first examined. The effect of protein expression on cellular proliferation and colony formations, an indication of cytotoxicity, were observed. Overall, there is a general correlation of subcellular localization of each viral protein between fission yeast and mammalian cells. Three viral proteins, viral protein R (Vpr), protease (PR) and regulator of expression of viral protein (Rev), were found to inhibit cellular proliferation. Rev was chosen for further analysis in fission yeast and mammalian cells. Consistent with the observation in fission yeast, expression of HIV-1 rev gene also caused growth retardation in mammalian cells. However, the observed growth delay was neither due to the cytotoxic effect nor due to alterations in cell cycling. Mechanistic testing of the Rev effect suggests it triggers transient induction of cellular oxidative stress.

Conclusions

Some of the behavioral and functional similarities of Rev between fission yeast and mammalian cells suggest fission yeast might be a useful model system for further studies of molecular functions of Rev and other HIV-1 viral proteins.

Keywords

HIV-1Viral genomeGene expressionFunctional analysisFission yeast Schizosaccharomyces pombe Subcellular localizationCellular proliferationColony formationOxidative stressMammalian cell

Background

The human immunodeficiency virus type 1 (HIV-1), like other retroviruses, is made up of an RNA encoded genome of approximately 9.7 kilobases (kb). Both ends of the RNA genome are flanked by a long terminal repeat (LTR) promoter region (Fig. 1). Between the two LTR regions, there are three polyproteins (Gag, Pol, Env), four accessory proteins (Vpu, Vif, Vpr, Nef) and two regulatory proteins (Rev, Tat). HIV-1 RNA also contains regulatory regions which are important for transcription initiation and polyadenylation.
Fig. 1

Schematic diagram of HIV-1 genome. The total size of HIV-1 genome is approximately 9.7 kb. Each of the viral genes is drawing based on the relative orientation in the entire RNA genome. Arrows points to cleaved protein products. Dashed lines represent RNA splicing. The number in parenthesis is molecular weight of each protein. LTR long-term repeat, Gag group-specific antigen, MA matrix protein, CA capsid domain, NC nucleocapsid, TF trans-frame protein, Pol polymerases, PR protease, RT reverse transcriptase, IN integrase, Env envelope protein, SU surface membrane protein, TM trans-membrane protein, Vif viral infectivity factor, Vpr viral protein R, Vpu viral protein U, Nef negative regulatory factor, Rev regulator of expression of viral proteins, Tat trans-activator of transcription.

The polyprotein Gag is required for both virion assembly and maturation [1, 2]. The Gag protein is cleaved by viral protease into P17, P24, P7, and P6 proteins shortly after budding from the host cell [1]. P17 (MA) protein lies in the inner surface membrane of matured viral particles [3]. It is important for RNA targeting of the plasma membrane prior to viral assembly, incorporation of the Env glycoprotein into the viral particle [4, 5] and the particle release [6, 7]. P24 (Capsid domain, CA) protein forms a shell surrounding the viral RNA genome and core-associated proteins in mature virion. It plays various roles including incorporation of the Gag-Pol precursor into virions during viral assembly [8], recruitment of the viral infectivity enhancing protein Cyclophilin A (CypA) [9–11], and early post entry [12]. P7 (Nucleocapsid, NC) plays important roles in the encapsulation and protection of viral RNA, promotion of viral assembly and in early post entry steps including reverse transcription [13]. P6 is important for Vpr packaging into the viral particle and virus budding from the cell membrane [14].

The Pol protein is expressed as a Gag–Pol fusion product since its gene lacks an initiation codon. It is subsequently cleaved by HIV-1 protease to produce MA, CA, NC, trans-frame protein (TF), viral enzymes protease (PR), reverse transcriptase (RT), and integrase (IN) [15]. PR cleaves the Gag and Pol precursors thus rendering the virion infectious [16]. RT is an asymmetric heterodimer with its main role to reverse transcribe viral RNA into pro-viral DNA prior to viral integration to host chromosomes [17]. Other functions of RT include RNA-directed DNA polymerase, DNA directed DNA polymerase and ribonuclease hybrid activities (RNase H) [18]. IN is active only as a tetramer and it is responsible for the integration of the linear double-stranded proviral DNA into the host cell chromosome [19].

The Env/gp160 protein is a precursor protein encoded by a spliced mRNA, which is subsequently cleaved by cellular proteases into the envelope gp120 surface membrane protein (SU) and gp41 trans-membrane protein (TM) [20]. The gp120 surface subunit harbors the N-terminal of the Gp160. It binds to cell receptors attaching virus to target cells and also regulates viral entry. Gp41 is the C-terminal 345-amino acid protein of gp160. It is also involved in the viral entry and mediation of fusion [21].

In addition to the retroviral Gag, Pol, and Env proteins, HIV-l produces four accessory proteins, i.e. Nef, Vif, Vpr and Vpu, and two regulatory protein, i.e. Tat, and Rev [22]. While Tat and Rev are required for viral replication, Nef, Vif, Vpr and Vpu are dispensable for viral proliferation in many of the in vitro systems [23, 24]. However, they are often necessary for viral replication and pathogenesis in vivo and for many of the essential viral functions during the viral life cycle.

The fission yeast Schizosaccharomyces pombe (S. pombe) is a unicellular eukaryote of the Division Ascomycota. It is cylindrical and rounded at both ends. It reproduces meiotically by ascospores and proliferates asexually by cell division (fission). Its length and diameter are about 7–12 µm and 3–4 µm, respectively [25, 26]. It has a relative small genomic size of about 1.5 × 1 07 bp in the haploid state [27]. S. pombe has many of the same fundamental cellular features as larger multicellular organisms which makes it very useful in many of the molecular-biological studies [25–28]. It contains gene slicing mechanism that is able to remove introns from genes of higher eukaryote and mammals [25, 27, 29]. Its signal-transduction system is able to transmit signals from the mating factor receptor through a G-protein-coupled system to the effectors [25]. The cell cycle is also similar to that in higher eukaryotes [27, 31]. For more than three decades, fission yeast has been used in many studies to investigate the structures, functions and expression of eukaryotic genes, especially from mammalian origins [25, 27, 29, 31]. It should also be mentioned that our laboratory has been using fission yeast as a model system to study the effect of HIV-1 Vpr on basic cellular functions in the past 20 years, which includes cell cycle G2/M regulation, nuclear transport and induction of cell death and apoptosis [31–36]. Results of those earlier studies have demonstrated the effects of Vpr are resembled, most of the time, to those of found in mammalian cells. Furthermore, this simple model system allowed us to discover new Vpr-specific activities that are otherwise difficult to uncover solely based on mammalian studies [37–41]. Our intention in this study was therefore to expand and to test whether we could also use fission yeast as a host system to study other HIV-1 proteins.

It should be mentioned that both fission yeast and budding yeast (Saccharomyces cerevisiae) have long been used to study various HIV-1 proteins. Some specific examples include HIV-1 Gag [31], Tat [32], Rev [33], Vpr [34], Vpx [35], Vpu [36], Integrase [42] and Protease [43], respectively. A number of reviews have also described the use of yeast as a model system for HIV-1 studies [44–47]. However, none of those early yeast studies has studied the whole HIV-1 genome all at once. Therefore our goal here was to carry out a genome-wide and functional analysis by cloning and expressing every viral gene encoded by the HIV genome in fission yeast. Subcellular localizations and effects of these viral proteins on fission yeast cell proliferation and colony formation, an indication of cytotoxicity, were observed and analyzed.

Results

Subcellular localizations of HIV-1 proteins in fission yeast

In order to determine the subcellular localization of HIV-1 proteins in fission yeast, SP223 cells were transformed with a fission yeast expression pYZ3N plasmid producing each of the HIV-1 viral protein sequences in fusion with an N-terminal GFP [48]. The fission yeast strains containing different viral proteins expressing plasmids were inoculated into liquid selective medium and the protein expression was induced following the removal of thiamine from the growth medium as described previously [34, 49]. After cultured for 24–30 h (depending on the intensity of green fluorescence), the GFP-viral fusion protein products were observed under a fluorescence microscope. As shown in Fig. 2a, GFP alone disperses throughout the cells indicating no preference of subcellular location. In contrast, the Gag protein aggregated in the cytoplasm of unknown sites. P17 protein was excluded from the nucleus and localized exclusively in the cytoplasm. P24 protein was localized both in the nucleus and cell membrane, while the P7 protein was predominantly localized in the nucleus. P6 was found distributed throughout the cell. The localizations of Pol proteins (P66, P51, IN, PR) and Env proteins (including Gp120 and Gp41) were monitored and shown in Fig. 2b. P66 was found more in the nucleus than in the cytoplasm; whereas P51 proteins were found exclusively in the cytoplasm. Consistent with the role of HIV-1 integrase, IN was indeed found more in the nucleus than in the cytoplasm. PR was distributed evenly throughout the cell, while Gp120 and Gp41 were localized more in the nucleus than in the cytoplasm. The subcellular distribution of HIV-1 accessory proteins (Vpr, Vpu, Vif, Nef, Rev, and Tat) was shown in Fig. 2c. Consistent with previous findings with Vpr [48], it localizes predominantly in the nucleus. Similarly, Vif, Rev, and Tat all accumulated in the nucleus of yeast cells. Nuclear localization of Tat has also been reported in budding yeast previously [50]. Vpu in cytoplasm but Nef was distributed throughout the cell. Finally, the subcellular location patterns observed in fission yeast were compared with that reported from mammalian cell studies. As summarized in Table 1, overall, there is a general correlation of the subcellular localization of each viral protein between fission yeast and that of previously reported in mammalian cells.
Fig. 2

Subcellular localization of HIV-1 proteins in fission yeast. Fission yeast strains expressing normal GFP or N-terminally GFP-tagged HIV-1 proteins were grown to a log phase in EMM selective media. The cells were re-inoculated into fresh media without thiamine (to induce gene expression) and grown for 24–30 h. The nuclei were stained with DAPI. The cells were examined using fluorescence microscopy for subcellular localizations of the GFP-tagged proteins with stained cellular nuclei. Each column represents different microscopic views: GFP, for protein subcellular location; DAPI, for localization of the nucleus; Merge, merging images of GFP and DAPI; and the “Contrast” is for the overall view of the cell. The Gag gene products are shown in a, the Pol and Env gene products in b, and the auxiliary and regulatory proteins in c. The scale bar represents 10 μm.

Table 1

Subcellular localization of HIV-1 proteins in mammalian and fission yeast cells

HIV-1 protein

Subcellular localization

Mammalian (references)

Fission yeast (this study)

Gag

Cytoplasmic membrane [51]

Cytoplasm

P17

Cytoplasm, membrane [52]

Cytoplasm

P24

Cytoplasmic membrane [53]

Nucleus and cell membrane

P7

Nucleus [54]

Nucleus

P6

Cytoplasmic membrane [55]

Throughout cella

P66

Cytoplasm [56]

Nuclear > cytoplasm

P51

Cytoplasm [56]

Cytoplasm

Integrase

Nucleus [57]

Nuclear > cytoplasm

Protease

No report found

Throughout cell

Gp120

No report found

Nuclear > cytoplasm

Gp41

No report found

Nuclear > cytoplasm

Vpr

Nucleic membrane [48]

Nucleus [58]

Vpu

Cytoplasm [59]

Cytoplasm

Vif

Nucleus [60]

Nucleus

Nef

Cytoplasm [61]

Throughout cella

Rev

Nucleus [62]

Nucleus

Tat

Nucleus [63]

Nucleus

aDifferent subcellular localization pattern was observed.

Effects of HIV-1 gene expression on yeast colony formation

To determine potential cytotoxic effect of HIV-1 viral protein expression on fission yeast, yeast colony formation, an indication of cellular growth and potential cytotoxicity, was measured. Fission yeast cells that were transformed with each one of the viral proteins via the inducible pYZ1N plasmids [48] were plated on selected agar plates under the gene-repressing (gene-Off) or gene-inducing (gene-On) conditions (Fig. 3). Correct nucleotide sequence of each viral gene carried on the pYZ1N plasmid was confirmed by Sanger sequencing. S. pombe cells transformed with pYZ1N-Vpr or an empty pYZ1N plasmid were used as positive and negative controls, respectively. We have reported previously that Vpr prevents colony formation whereas pYZ1N plasmid has no cytotoxic effect on cells [34, 64]. As shown in Fig. 3, all HIV-1 viral gene-repressing (gene-Off) cells formed colonies as anticipated. On the gene-inducing (gene-On) plates, as expected, cells containing the empty pYZ1N plasmid formed colonies but HIV-1 Vpr prevented colony formation. Most of the HIV-1 viral gene expressions in fission yeast did not show any cytotoxic effects as they formed the same sizes of colony as the pYZ1N control. In contrast, however, the fission yeast strains expressing rev and PR showed much reduced or no colony formation indicating inhibition of cell growth or possible cytotoxic effects following expression of the respective genes.
Fig. 3

Effects of HIV-1 viral proteins on colony formation. Wild type S. pombe cells containing HIV-1 viral gene-expressing plasmids were grown overnight in EMM liquid medium supplemented with thiamine to mid-log phase. The following day, cells were recovered, re-suspended in fresh media and streaked onto the minimal selection EMM agar plates with thiamine (left +T plates; no gene expression) or without thiamine (right −T plates; with gene expression). The plates were incubated at 30°C for 6 days before observation. The pYZ1N-vpr and pYZ1N plasmids were used as positive and negative controls, respectively [34].

Effects of HIV-1 rev gene expression on yeast cell growth

To further differentiate the inhibitory effect of HIV-1 Rev protein on the cellular growth or toxicity of yeast cells, we measured the growth kinetics of S. pombe cells with and without rev gene expression. S. pombe cells containing pYZ1N-rev and pYZ1N control vectors were grown under gene-repressing (+T) and gene-inducing (−T) conditions in liquid minimal and selective EMM medium. Cellular growth was measured by the optical density (OD) over time from 0 to 122 h (5 days). At the first 24 h, both cells grown at the same pace with a doubling time of approx. 24 h. After 24 h of gene induction when the rev gene expression was fully expressed [34, 65], the growth velocity of Rev-producing cells became slower than those without rev gene expression that was grown actively in a logarithmic fashion (Fig. 4a). By 48 h, i.e., 2 days after rev gene induction, the difference in growth between rev-expressing and rev-repressing cells reached to the maximum level. As control, the pYZ1N transformed yeast cells showed no difference in growth of neither gene-repressing nor gene-inducing condition.
Fig. 4

Effect of HIV-1 Rev protein production on fission yeast. a Expression of HIV-1 rev delays cellular growth of S. pombe. S. pombe cells containing pYZ1N-rev was grown under gene-repressing (+T) and gene-inducing (−T) conditions in liquid minimal selection EMM at 30°C. The cell density was measured over time and growth curves were plotted. S. pombe cell containing pYZ1N was used as a control. The experiment was repeated three times and the standard errors of each time point were calculated. b Rev delays colony formation in fission yeast cells. A semi-quantitative colony dot dilution assay was use to evaluate the ability of individual rev-expressing S. pombe cells to form colonies on agar plates. The pYZ1N-rev transformed S. pombe cells were grown in liquid EMM medium to log phase with thiamine. Thiamine was then removed from cells by washing and equal number of cells transferred to EMM supplemented plates with (gene-off, left plate) and without (gene-on, right plate) thiamine. The plates were incubated at 30°C for 5 days. Each colony on a plate from left to right (1–6) represents cells plated from approximately 1,000 to 3 cells following threefold dilutions. The pYZ1N plasmid was used as a control. c Rev does not affect cell cycle of fission yeast. Cell cycle profiles were measured in the pYZ1N-rev and pYZ1N control S. pombe cells by flow cytometric analysis. The data show analyses after 24 and 67 h of cell culture in EMM selective media with (gene-off) and without (gene-on) thiamine. The cell cycle stages were monitored after staining with propidium iodide. The up-right numbers are the percentage of cells in G1, S and G2 phases of the cell cycle.

Fig. 5

Expression of rev stimulates production of reactive oxygen species (ROS) in S. pombe cells. Fission yeast strain carrying pYZ1N-rev was grown in selective EMM either in the presence (+T) or absence (−T) of thiamine to suppressor or induce rev gene induction, respectively. a ROS production was detected by addition of a ROS indicator dye (DHE) to the culture medium right before microscopic observation overtime at different times as indicated. An oxygen radical scavenger (TMPO) was also added in separate test tubes but concurrently to test the specific production of ROS. TMPO was added twice during the course of the rev expression. TMPO was first added to the culture at the time of cell inoculation when rev gene expression was induced, and cells were treated again with TMPO when DHE was added to the culture to detect ROS production. DHE DHE-positive cells, DIC cells shown by differential interference contrast. Scale bar 10 μm. b Percentage of ROS-producing cells induced by HIV-1 Rev decreases over time. The % of ROS-producing cells induced by HIV-1 Rev was quantified by counting the numbers of DHE-positive cells over the entire cell population of three independent experiments.

Rev causes growth delay but not cell death

Retarded cell growth could be an indication of cell death due to cytotoxicity. So we checked whether the growth delay caused by Rev was due to cell death. A semi-quantitative colony dot dilution assay was used, which quantified the ability of individual cells to form colonies on agar plate. All of the cells expressing rev formed colonies with expected numbers on each agar plate although the colony sizes were much smaller (Fig. 4b). This observation suggested that Rev causes growth delay but not cell death. Therefore, Rev causes growth delay but not cell death.

Rev does not affect cell cycling of fission yeast

Because Rev affects cellular growth of fission yeast cells, we were interested in testing whether it affects the distribution of cell cycles. The cell cycle profile of S. pombe cells containing rev-expressing plasmid was monitored by flow cytometry. In standard EMM medium, S. pombe cells normally reside predominantly in the G2 phase of the cell cycle [66]. If Rev induces G1 delay, we should expect a shift of the predominantly G2 cell population to G1 after the production of Rev protein. Similarly, Rev-induced G2 delay should be represented by no shift of G2 cell population to G1 in the EMM medium. In this experiment, production of HIV-1 Rev protein did not change the cell cycle profile (Fig. 4c). Consistently, the pYZ1N vector was used as a control and showed no cell cycle difference between gene-repressing (+T) and gene-inducing (−T) conditions.

Rev stimulates the production of reactive oxygen species (ROS)

To further explore the possible molecular mechanism underlying Rev-induced growth delay, possible intracellular stress induced by Rev was measured by probable production of ROS. A ROS-specific dye, DHE that produces red fluorescence in the presence of ROS, was used to measure possible cellular oxidative stress in rev-expressing cells. A ROS scavenger TMPO that can specifically remove free radicals by forming stable complexes [67], was also used as a control to verify the specific production of ROS. Expression of HIV-1 rev was induced in a fission yeast strain carrying the pYZ1N-rev plasmid, and the level of ROS was subsequently detected in cells at 21, 24, and 30 h after rev gene induction (Fig. 5). At 21 h, strong red fluorescence was detected in the rev-expressing cells; whereas little or no red fluorescence was observed in the rev-repressing cells (Fig. 5a). Consistently, treatment of the same rev-expressing cells with the ROS scavenger TMPO significantly reduced intensity of the red fluorescence suggesting the observed ROS production is Rev specific. Interestingly, Rev-induced ROS production faded away very quickly (Fig. 5b). About half of the rev-expressing cells produced the ROS signals 21 h after rev gene induction. Less than 30% of the cells showed ROS production 3 h later and a little more than 10% of those cells were DHE-positive by 30 h after gene induction. Together these data suggest expression of HIV-1 rev gene in fission yeast triggers intracellular oxidative stress. However, such a cellular stress response might be transient, which could potentially explain at least in part why those rev-expressing cells slowed cell growth but did not die.

Effect of Rev protein on mammalian cell growth

Since HIV-1 Rev caused growth delay in S. pombe, we were interested in whether the same effect could also be observed in mammalian cells. In order to observe the effect of Rev protein on mammalian cellular growth, we created a mammalian gene inducible system to produce Rev. The HIV-1 rev gene was cloned into the mammalian cell expressing vector pZH-1 and transfected into 293VE632 cells [68]. The transfected cells were selected with hygromycin. After exerting drug selection for 2 weeks, Rev protein production was tested by inducing its expression with muristerone A. The cell lysate were collected and monoclonal anti-Rev antibody was used to confirm the expression of Rev protein (Fig. 6a). It was anticipated that if Rev affects mammalian cell growth, there should be a difference of cell numbers between rev-expressing and rev-repressing cells. The cell numbers of rev-containing 293VE632 cells were counted with Trypan blue staining under rev-repressing and rev-inducing conditions, and growth curves were generated. Indeed, there was a diverging growth differences between rev-expressing and rev-repressing cells after 5 days of culture (Fig. 6b). Finally, we tested whether the Rev-induced growth delay was due to, or at least partially due to alteration in cell cycling. To test this, 293VE632 cells containing pZH-1 and pZH-rev were cultured under the rev-repressing and rev-inducing conditions. Following gene induction for 5 days, the cells were harvested and the DNA contents were measured by flow cytometry as described in the materials and methods. No significant differences in cell cycle distributions were seen between rev-expressing and other control 293VE632 cells (Fig. 6c). Therefore, consistent with our observations in fission yeast, Rev also reduces mammalian cellular growth but does not affect its cell cycle distribution.
Fig. 6

Effect of HIV-1 Rev in mammalian cells. a Stable expression of HIV-1 rev gene in 293VE632 cells. The inducible pZH-1-rev plasmid was transfected into 293VE632 cells. The rev gene was expressed following addition of muristerone A and confirmed by Western blot analysis using a HIV-1 Rev monoclonal antibody. Lane “Off”, rev-repressing 293VE632 cells; lane “On”, rev-expressing 293VE632 cells. Western blot shows a 13 kDa protein band that was reacted to the anti-Rev antibody. β-actin was used as a loading control. b The 293VE632 cells containing the pZH-1-rev plasmid were grown under gene-repressing (rev-Off) and gene-inducing (rev-On) conditions for up to 7 days. The cells were collected every 24 h, and the cell numbers were counted with Tryptan blue staining (Sigma-Aldrich) [69]. The growth curves were generated with an average of three different experiments. c Rev does not affect mammalian cell cycle. The 293VE632 cells transfected with pZH-1 and pZH-1-rev plasmids were cultured without muristerone A (rev-Off) or with muristerone A (rev-On). DNA contents of the cells were determined by flow cytometric analyses after 5 days of culture. The upright numbers are the percentage of cells in the G1, S and G2 phases of the cell cycle. The 293VE632 cells containing pZH-1 plasmid was used as a control (upper row).

Discussion

Maintaining faithful viral production during HIV-1 infection requires highly coordinated production of each individual viral protein and orchestration of the entire protein complexes. Each viral protein has to interact with host cellular proteins at defined subcellular sites to ensure successful completion each step of the viral life cycle. Identification of subcellular localization of all viral proteins encoded by HIV-1 is therefore a key step towards a comprehensive understanding of viral production and their potential effects on basic cellular functions. Here, we demonstrated the subcellular localizations of all HIV-1 viral proteins in fission yeast cells. This might be the first effort to illustrate the subcellular localizations of the entire HIV-1 genome all at once in a single cellular system. The use of GFP tagging allows the selective and specific detection of HIV-1 proteins at very low concentrations with good signal-to-background ratio. Combined information on HIV-1 viral protein subcellular localization with genome-wide protein–protein interaction data will be instrumental in establishing the interrelationships between the viral and host cellular proteins that determine virologic functions of the virus [70].

In fission yeast, we observed that HIV-1 P24, P7, P66, P51, IN, Gp120, Gp41, Vpr, Vif, Rev and Tat are all predominantly localized in the nuclei (Fig. 2). Please note that nuclear localization of Vpr has long been established in our laboratory [48]. It was used as a positive control here to confirm appropriate experimental conditions. The P17 and Vpu are primarily localized in the cytoplasm, which is consistent with previous findings in mammalian cells [59]. Also, the Gag precursor protein was seen to aggregate in the cytoplasm of unknown sites that resembles mammalian report [51]. The PR and Nef did not seem have any preference but distributed throughout the cell. Based on the previous reports on subcellular localizations of HIV-1 viral proteins in mammalian cells, there is a general correlation between fission yeast and mammalian cells (Table 1).

We further examined the potential growth or cytotoxic effects of the viral gene expressions on fission yeast cells. While most of the HIV-1 viral protein productions have no inhibitory effects on colony formation in fission yeast, Vpr, PR and Rev showed significant inhibitory effects (Fig. 3). The effect of Vpr has been studied extensively before [34, 37–40, 48]. Rev was chosen here for further analysis (Note: we have carried out subsequent and extensive studies on PR that will be described elsewhere).

HIV-1 Rev is an 18 kD phosphoprotein with 116 amino acids that contains a nuclear localization signal (NLS) and nuclear export signal (NES) [71, 72]. Thus it is capable of shutting between the cytoplasm and nucleus where it also specifically bind to the Rev responsive element (RRE) for nuclear transport of HIV-1 RNAs. In HIV-infected cells, HIV-1 Rev protein is located predominantly in the nucleus/nucleolus [73–75]. In addition, Rev is also a shutting protein between the nucleus and cytoplasm [75]. Thus it was not surprising that Rev was found to localize predominantly in the nucleus but also in the cytoplasm of the fission yeast cells (Fig. 2c, 5th row). Rev is a “nuclear regulatory protein” [76]. Mechanistically, Rev was found in the nucleus of mammalian and budding yeast cells where they both interact with a small nucleoporin-like protein hRIP/RAB1 and yRip1p, respectively [62, 77]. Thus it would be interesting in the future to test whether Rev also interact with a similar nucleoporin-like protein in fission yeast. In addition, we found that the production of HIV-1 Rev protein appeared to slow down cellular growth in both fission yeast and mammalian cells. However, Rev does not appear to induce cell death in proliferating cells but reduced the size of yeast colony formation (Fig. 4b) and the number of mammalian cells (Fig. 6b) presumably due to growth retardation. Consistently, there has been no report of Rev causing death in actively dividing mammalian cells. Interestingly, however, overproduction of Rev has been reported to cause death of non-dividing human cells [78]. In an attempt to resolve this potential discrepancy, we have explored possible molecular mechanism underlying Rev-induced growth delay revealed that expression of HIV-1 rev gene in fission yeast triggers transient production of ROS indicating fission yeast cells were experiencing intracellular oxidative stress upon Rev production (Fig. 5). Typically, upon induction of cellular oxidative stress, large amounts of ROS are released from mitochondria within the cell that often cause cell death [79, 80]. Paradoxically, no cell death was observed in the rev-producing cells. One possible explanation could be due to the rapid dissipation of the cellular stress response in continue dividing cells. Conceivably, possible accumulation of ROS production in non-dividing cells could potentially contribute to the cell death caused by Rev [78]. Test of this possibility will be our future goal of the study.

Even though Rev causes significant growth delay in fission yeast (Fig. 4a) and mammalian cells (Fig. 6b), it does not affect distributions of neither cell cycles (Figs. 3c, 6c). Altogether, our data suggested that Rev is a nuclear protein that reduces cellular proliferation in both fission yeast and mammalian cells. However, it does not affect cell cycling with minimal or no cytotoxic effect at least in proliferating cells. Future studies on molecular actions of HIV-1 Rev are important because expression of HIV-1 Rev protein is essential for completion of the viral life cycle [78, 81]. In particular, by localizing in the nucleus, Rev mediates nuclear export of partially spliced and un-spliced viral transcripts and its nuclear export signal allows nucleocytoplasmic shuttling [78, 81]. Therefore, Rev plays a pivotal role in viral replication. Conceivably, inhibition of its activities should block HIV-1 viral replication thus infection.

In summary, we successfully cloned and expressed all of the HIV-1 viral genes in S. pombe. By using a fission yeast inducible nmt1 promoter, we were able to demonstrate the specific effects of viral proteins on fission yeast. In particular, we observed that, most of the viral proteins localized at the same or similar subcellular sites to human cells, suggesting fission yeast could be used as a simple and suitable model for future analysis of some of the HIV-1 proteins. Interestingly, besides HIV-1 Vpr, we found that HIV-1 PR and Rev also inhibit colony formation of fission yeast. Additional analysis of Rev suggested that there are a number of functional resemblances of the Rev effect between fission yeast and mammalian cells. These physical and similar effects on cellular functions suggest similar molecular mechanism of actions for HIV-1 Rev in yeast and mammalian cells, despite their evolutionary distance. Therefore, fission yeast might be suited as a model system for further investigation of this viral protein.

Methods

Cell and growth media

SP223, a wild-type S. pombe strain (h-, ade6-216, leu1-32, ura4-294), was used in this study [27, 34]. Standard YES complete and EMM minimal media supplemented with adenine, uracil, leucine or thiamine (20 µM) when necessary, were used for yeast cell culture and growth. Solid Luria–Bertani (LB) medium supplemented with Ampicillin (100 µg/ml) was used for competent E. coli Top 10 cell transformation. Mammalian 293VE632 cell was used to create a rev-inducible gene expression system. This is a stable zeocin-resistant mammalian cell line [68] expressing a heterodimer of the modified ecdysone receptor (VgEcR) and the retinoid X receptor. The heterodimer binds to a hybrid ecdysone response element (ECRE) only in the presence of the synthetic analogue of ecdysone, muristerone A, thus leading to induction of HIV-1 rev gene expression [82, 83]. The mammalian cell lines were maintained in Dulbecco’s modified Eagle (DMEM) medium containing 10% FBS, 100 µg/ml Zeocin (Invitrogen).

Plasmids

pYZ1N and pYZ3N were used as previously described [48] for inducible viral gene expressions in fission yeast cells. These plasmids carry a n o m essage in t hiamine (nmt1) promoter. Under this inducible gene expression system, viral gene expression can be repressed or induced in the presence or absence of thiamine, respectively [65, 84]. These plasmids carry the leu2 gene as a selection marker. In pYZ3N, GFP is fused to the viral gene at its 5′ end that was used to visualize intracellular location of each viral protein. For mammalian studies, a muristerone A-inducible gene expression pZH-1 plasmid was used as described previously [68].

Molecular cloning of HIV-1 genes in fission yeast and mammalian cells

The plasmid pNL4-3, which carries an entire HIV-1 genome, was used as a template for viral gene cloning with the exception of rev and tat genes. The PSV-Rev plasmid, which carries a rev cDNA and originated from a HIV-1 cDNA clone pCV1, was used and obtained from the NIH AIDS Reagent Program [85]. The ptatC6H plasmid carrying the tat cDNA was used, which was a gift from Dr. David Pauza and originated from [86]. For mammalian studies, the rev gene was cloned in pZH-1 and gene expression was induced in 293VE632 cells by adding 1 µM muristerone A to the growth medium [68].

Recombinant DNA transformation and gene expression

Each of the viral genes was PCR amplified, cloned and confirmed by Sanger DNA sequencing. The confirmed recombinant DNA was transformed into SP223 cells by electroporation using the BTX ECM600 protocol 0226 [87]. The transformants were selected on a minimal selective medium. For viral gene expression, a single yeast colony, which carries viral gene-containing plasmids, was grown to log phase on specific EMM liquid medium supplemented with 20 μM thiamine. The cells were then harvested and washed to remove the thiamine. Finally, 2 × 105 cells/ml were grown and tested in fresh specific EMM liquid medium with thiamine (gene-Off) and without thiamine (gene-On). The cell suspensions were incubated at 30°C with constant shaking before observations.

Subcellular localization of HIV-1 viral proteins in fission yeast

The HIV-1 viral proteins fused to GFP at their 5′ ends in pYZ3N were expressed and their subcellular localizations were visualized by fluorescent microscopy. Prior to visualization, the nucleus of the cells were stained with a nuclear dye 4′,6′ diamino-2-phenylindole (DAPI). Briefly, thiamine was washed out of a log phase culture with distilled water. The cells were inoculated in a thiamine free minimal media and incubated for at least 14 h for gene expression. The cells were then collected by spinning at 3,000 rpm for 5 min and re-suspended in suitable EMM medium. For DAPI staining, 5 µl of the cell suspension was pipetted onto a glass slide. The cells were heat fixed for 1 min at 70°C on a hot plate. The slide was then cooled down for a few seconds before counterstained with 1 µg/ml final concentration of DAPI. A coverslip was applied and the cells visualized under a fluorescence microscopy. A Leica DMR fluorescence microscope equipped with a high performance charge-coupled device camera (Hamamatsu) and Open-Lab software (Improvision, Inc., Lexington, MA, USA) was used for all imaging analysis. For DAPI, the cells were observed with a Leica A8 filter with an excitation of 360 nm (ranged from 340 to 380 nm) and emission of 470 nm (range, 450 to 490 nm). For the observation of GFP, a Leica L5 filter, which has an excitation of 480 nm (ranged from 460 to 500 nm) and emission of 527 nm (ranged from 512 to 542 nm), was used.

Effect of HIV-1 viral proteins on yeast colony formation

A single yeast colony, which carries viral gene-containing plasmids, was picked from a selective minimal plate and inoculated overnight in specific EMM liquid medium supplemented with thiamine. The following day, 1 ml of a mid-log phase culture was spin down, washed three times with distilled water and the cells re-suspended in appropriate volume of water. About 1–5 µl were streaked onto selective EMM plates with and without thiamine. The plates were incubated at 30°C for 6 days to observe for colony formation and numbers of cells within each colony (at low dilutions) as a semi-quantitative indicator of the viral effect on cellular growth or cytotoxicity.

Characterization of HIV-1 Rev protein activities in fission yeast

Apart from the colony formation assay on agar plates, the effect of Rev on yeast cell proliferation was also determined by growth kinetics analyses as previously described [34]. Cell cycle profile of rev-expressing cells was measured by flow cytometry using a previously described method [31, 49]. A semi-quantitative growth and colony dot test was also used to quantify the effect of Rev on yeast cellular growth and colony formation. Briefly, the cells were grown to a log phase in liquid EMM as previously described and washed to remove thiamine. Cell suspension of 5 × 105 cells/ml was made on a 96 well plate and five consecutive threefold dilutions were made. Using a multiple pipette, 2 µL spots were generated on EMM supplemented media with (gene-off) and without (gene-on) thiamine. The plates were incubated at 30°C for 5 days to observe for colony formation. Fission yeast cells that were transformed with an empty pYZ1N vector were used as control. Potential effect of Rev on cellular oxidative stress was measured by production of reactive oxygen species (ROS), which can be detected by a ROS-specific dye, dihydroethidium (DHE) that produces red fluorescence in the presence of ROS as described previously [39]. A ROS scavenger, 3,3,5,5-tetramethylpyrroline N-oxyde (TMPO) was used as a control to specifically remove ROS [71].

Characterization of Rev-specific activities in mammalian cells

A Rev protein-inducible mammalian system was created and used for growth kinetics measurement as well as for analysis of cell cycle profile. For growth kinetics measurement, the Rev protein was expressed in transfected 293VE632 cells following the addition of muristerone A. Protein expression was confirmed by Western Blot analysis using a monoclonal anti-Rev antibody as previously described [40]. Viable cells were grown in equal numbers in both rev-inducing and rev-repressing conditions for 7 days. The number of viable cells were counted by observation of differential stainings of the Trypan Blue (Sigma-Aldrich) [69]. Finally, for cell cycle profile measurement, 293VE632 cells containing pZH-1 (control cells) and pZH-1-rev were cultured under rev-repressing and rev-inducing conditions as mentioned before. Following gene induction of 5 days, the cells were harvested and prepared for flow cytometry as described [40, 41]. The DNA contents of the cells were analyzed on a FACScan flow cytometry device (Becton–Dickinson) using the Cell Quest software.

Notes

Declarations

Authors’ contributions

JN participated in data analyses and writing the manuscript. LL carried out most of the initial experiments. ZB carried out some of the fission yeast experiments. GL conducted the ROS tests. RYZ designed the experiments and participated in writing of the manuscript. All authors read and approved the final manuscript.

Acknowledgements

The authors would like to thank Dong Liang for critical reading and comments on this manuscript, Jianneng Dai for assistance in figure preparation. The mammalian expression vectors pZH-1 was a gift from Lee Ratner at the Department of Medicine and Molecular Microbiology, Washington University School of Medicine, St. Louis, Missouri. The plasmids PSV-Rev and PtatC6H were gifts from the NIH AIDS Reagent Program and Dr. David Pauza (UMB), respectively. This work was also submitted in partial fulfillment of Lin Li’s Doctoral Dissertation.

Compliance with ethical guidelines

Competing interests The authors declare that they have no competing interests.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Division of Molecular Pathology, Department of Pathology, University of Maryland School of Medicine, Baltimore, USA
(2)
Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, USA
(3)
Institute of Human Virology, University of Maryland School of Medicine, Baltimore, USA
(4)
AIDS Research Department, Beijing Institute of Microbiology and Epidemiology, Beijing, China
(5)
Department of Chromosome Biology, Max F. Perutz Laboratories, University of Vienna, Vienna, Austria

References

  1. Freed EO. HIV-1 gag proteins: diverse functions in the virus life cycle. Virology. 1998;251(1):1–15.PubMedView ArticleGoogle Scholar
  2. Gottlinger HG. The HIV-1 assembly machine. Aids. 2001;15(Suppl 5):S13–20.PubMedView ArticleGoogle Scholar
  3. Wilk T, Geiselhart V, Frech M, Fuller SD, Flugel RM, Lochelt M. Specific interaction of a novel foamy virus Env leader protein with the N-terminal Gag domain. J Virol. 2001;75(17):7995–8007PubMedView ArticleGoogle Scholar
  4. Freed EO, Martin MA. The role of human immunodeficiency virus type 1 envelope glycoproteins in virus infection. J Biol Chem. 1995;270(41):23883–6.PubMedView ArticleGoogle Scholar
  5. Mammano F, Kondo E, Sodroski J, Bukovsky A, Gottlinger HG. Rescue of human immunodeficiency virus type 1 matrix protein mutants by envelope glycoproteins with short cytoplasmic domains. J Virol. 1995;69(6):3824–30PubMedGoogle Scholar
  6. Deora A, Spearman P, Ratner L. The N-terminal matrix domain of HIV-1 Gag is sufficient but not necessary for viral protein U-mediated enhancement of particle release through a membrane-targeting mechanism. Virology. 2000;269(2):305–12.PubMedView ArticleGoogle Scholar
  7. Gallay P, Swingler S, Song J, Bushman F, Trono D. HIV nuclear import is governed by the phosphotyrosine-mediated binding of matrix to the core domain of integrase. Cell. 1995;83(4):569–76PubMedView ArticleGoogle Scholar
  8. Accola MA, Strack B, Gottlinger HG. Efficient particle production by minimal Gag constructs which retain the carboxy-terminal domain of human immunodeficiency virus type 1 capsid-p2 and a late assembly domain. J Virol. 2000;74(12):5395–402.PubMedView ArticleGoogle Scholar
  9. Braaten D, Ansari H, Luban J. The hydrophobic pocket of cyclophilin is the binding site for the human immunodeficiency virus type 1 Gag polyprotein. J Virol. 1997;71(3):2107–13.PubMedGoogle Scholar
  10. Kootstra NA, Munk C, Tonnu N, Landau NR, Verma IM. Abrogation of postentry restriction of HIV-1-based lentiviral vector transduction in simian cells. Proc Natl Acad Sci USA. 2003;100(3):1298–303PubMedView ArticleGoogle Scholar
  11. Thali M, Bukovsky A, Kondo E, Rosenwirth B, Walsh CT, Sodroski J, et al. Functional association of cyclophilin A with HIV-1 virions. Nature. 1994;372(6504):363–5PubMedView ArticleGoogle Scholar
  12. von Schwedler UK, Stemmler TL, Klishko VY, Li S, Albertine KH, Davis DR, et al. Proteolytic refolding of the HIV-1 capsid protein amino-terminus facilitates viral core assembly. EMBO J. 1998;17(6):1555–68View ArticleGoogle Scholar
  13. Carroll SS, Olsen DB, Bennett CD, Gotlib L, Graham DJ, Condra JH, et al. Inhibition of HIV-1 reverse transcriptase by pyridinone derivatives. Potency, binding characteristics, and effect of template sequence. J Biol Chem. 1993;268(1):276–81PubMedGoogle Scholar
  14. Lu M, Blacklow SC, Kim PS. A trimeric structural domain of the HIV-1 transmembrane glycoprotein. Nat Struct Biol. 1995;2(12):1075–82.PubMedView ArticleGoogle Scholar
  15. Hill M, Tachedjian G, Mak J. The packaging and maturation of the HIV-1 Pol proteins. Curr HIV Res. 2005;3(1):73–85.PubMedView ArticleGoogle Scholar
  16. Pearl LH, Taylor WR. A structural model for the retroviral proteases. Nature. 1987;329(6137):351–4.PubMedView ArticleGoogle Scholar
  17. Hoffman AD, Banapour B, Levy JA. Characterization of the AIDS-associated retrovirus reverse transcriptase and optimal conditions for its detection in virions. Virology. 1985;147(2):326–35.PubMedView ArticleGoogle Scholar
  18. Oude Essink BB, Das AT, Berkhout B. HIV-1 reverse transcriptase discriminates against non-self tRNA primers. J Mol Biol. 1996;264(2):243–54.PubMedView ArticleGoogle Scholar
  19. Chiu TK, Davies DR. Structure and function of HIV-1 integrase. Curr Top Med Chem. 2004;4(9):965–77.PubMedView ArticleGoogle Scholar
  20. McCune JM, Rabin LB, Feinberg MB, Lieberman M, Kosek JC, Reyes GR, et al. Endoproteolytic cleavage of gp160 is required for the activation of human immunodeficiency virus. Cell. 1988;53(1):55–67PubMedView ArticleGoogle Scholar
  21. Weiss CD. HIV-1 gp41: mediator of fusion and target for inhibition. AIDS Rev. 2003;5(4):214–21.PubMedGoogle Scholar
  22. Li L, Li HS, Pauza CD, Bukrinsky M, Zhao RY. Roles of HIV-1 auxiliary proteins in viral pathogenesis and host–pathogen interactions. Cell Res. 2005;15(11–12):923–34PubMedView ArticleGoogle Scholar
  23. Fan L, Peden K. Cell-free transmission of Vif mutants of HIV-1. Virology. 1992;190(1):19–29.PubMedView ArticleGoogle Scholar
  24. Strebel K, Klimkait T, Martin MA. A novel gene of HIV-1, vpu, and its 16-kilodalton product. Science. 1988;241(4870):1221–3.PubMedView ArticleGoogle Scholar
  25. Giga-Hama Y, Kumagai H. Expression system for foreign genes using the fission yeast Schizosaccharomyces pombe. Biotechnol Appl Biochem. 1999;30(Pt 3):235–44.PubMedGoogle Scholar
  26. Piel M, Tran PT. Cell shape and cell division in fission yeast. Curr Biol. 2009;19(17):R823–7.PubMedView ArticleGoogle Scholar
  27. Zhao Y, Lieberman HB. Schizosaccharomyces pombe: a model for molecular studies of eukaryotic genes. DNA Cell Biol. 1995;14(5):359–71.PubMedView ArticleGoogle Scholar
  28. Chino A, Watanabe K, Moriya H. Plasmid construction using recombination activity in the fission yeast Schizosaccharomyces pombe. PLoS One. 2010;5(3):e9652.PubMedView ArticleGoogle Scholar
  29. Lu Q, Bauer JC, Greener A. Using Schizosaccharomyces pombe as a host for expression and purification of eukaryotic proteins. Gene. 1997;200(1–2):135–44.PubMedView ArticleGoogle Scholar
  30. Takegawa K, Tohda H, Sasaki M, Idiris A, Ohashi T, Mukaiyama H, et al. Production of heterologous proteins using the fission-yeast (Schizosaccharomyces pombe) expression system. Biotechnol Appl Biochem. 2009;53(Pt 4):227–35PubMedView ArticleGoogle Scholar
  31. Jacobs E, Gheysen D, Thines D, Francotte M, de Wilde M. The HIV-1 Gag precursor Pr55gag synthesized in yeast is myristoylated and targeted to the plasma membrane. Gene. 1989;79(1):71–81PubMedView ArticleGoogle Scholar
  32. Toyama R, Bende SM, Dhar R. Transcriptional activity of the human immunodeficiency virus-1 LTR promoter in fission yeast Schizosaccharomyces pombe. Nucleic Acids Res. 1992;20(10):2591–6.PubMedView ArticleGoogle Scholar
  33. Stutz F, Rosbash M. A functional interaction between Rev and yeast pre-mRNA is related to splicing complex formation. EMBO J. 1994;13(17):4096–104.PubMedGoogle Scholar
  34. Zhao Y, Cao J, O'Gorman MR, Yu M, Yogev R. Effect of human immunodeficiency virus type 1 protein R (vpr) gene expression on basic cellular function of fission yeast Schizosaccharomyces pombe. J Virol. 1996;70(9):5821–6PubMedGoogle Scholar
  35. Zhang C, Rasmussen C, Chang LJ. Cell cycle inhibitory effects of HIV and SIV Vpr and Vpx in the yeast Schizosaccharomyces pombe. Virology. 1997;230(1):103–12.PubMedView ArticleGoogle Scholar
  36. Herrero L, Monroy N, Gonzalez ME. HIV-1 Vpu protein mediates the transport of potassium in Saccharomyces cerevisiae. Biochemistry. 2013;52(1):171–7.PubMedView ArticleGoogle Scholar
  37. Benko Z, Liang D, Agbottah E, Hou J, Chiu K, Yu M, et al. Anti-Vpr activity of a yeast chaperone protein. J Virol. 2004;78(20):11016–29PubMedView ArticleGoogle Scholar
  38. Elder RT, Yu M, Chen M, Edelson S, Zhao Y. Cell cycle G2 arrest induced by HIV-1 Vpr in fission yeast (Schizosaccharomyces pombe) is independent of cell death and early genes in the DNA damage checkpoint. Virus Res. 2000;68(2):161–73PubMedView ArticleGoogle Scholar
  39. Huard S, Chen M, Burdette KE, Fenyvuesvolgyi C, Yu M, Elder RT, et al. HIV-1 Vpr-induced cell death in Schizosaccharomyces pombe is reminiscent of apoptosis. Cell Res. 2008;18(9):961–73PubMedView ArticleGoogle Scholar
  40. Li G, Park HU, Liang D, Zhao RY. Cell cycle G2/M arrest through an S phase-dependent mechanism by HIV-1 viral protein R. Retrovirology. 2010;7:59PubMedView ArticleGoogle Scholar
  41. Iordanskiy S, Zhao Y, Dubrovsky L, Iordanskaya T, Chen M, Liang D, et al. Heat shock protein 70 protects cells from cell cycle arrest and apoptosis induced by human immunodeficiency virus type 1 viral protein R. J Virol. 2004;78(18):9697–704PubMedView ArticleGoogle Scholar
  42. Caumont AB, Jamieson GA, Pichuantes S, Nguyen AT, Litvak S, Dupont C. Expression of functional HIV-1 integrase in the yeast Saccharomyces cerevisiae leads to the emergence of a lethal phenotype: potential use for inhibitor screening. Curr Genet. 1996;29(6):503–10PubMedView ArticleGoogle Scholar
  43. Blanco R, Carrasco L, Ventoso I. Cell killing by HIV-1 protease. J Biol Chem. 2003;278(2):1086–93.PubMedView ArticleGoogle Scholar
  44. Zhao Y, Elder RT. Yeast perspectives on HIV-1 Vpr. Front Biosci. 2000;5:905–16.View ArticleGoogle Scholar
  45. Zhao RY, Bukrinsky M, Elder RT. HIV-1 viral protein R (Vpr) and host cellular responses. Indian J Med Res. 2005;121(4):270–86.PubMedGoogle Scholar
  46. Li G, Bukrinsky M, Zhao RY. HIV-1 viral protein R (Vpr) and its interactions with host cell. Curr HIV Res. 2009;7(2):178–83.PubMedView ArticleGoogle Scholar
  47. Andreola ML, Litvak S. Yeast and the AIDS virus: the odd couple. J Biomed Biotechnol. 2012;2012:549020.PubMedView ArticleGoogle Scholar
  48. Zhao Y, Elder RT, Chen M, Cao J. Fission yeast expression vectors adapted for positive identification of gene insertion and green fluorescent protein fusion. Biotechniques. 1998;25(3):438–40, 42, 44Google Scholar
  49. Maundrell K. Thiamine-repressible expression vectors pREP and pRIP for fission yeast. Gene. 1993;123(1):127–30.PubMedView ArticleGoogle Scholar
  50. Braddock M, Chambers A, Wilson W, Esnouf MP, Adams SE, Kingsman AJ, et al. HIV-1 TAT “activates” presynthesized RNA in the nucleus. Cell. 1989;58(2):269–79PubMedView ArticleGoogle Scholar
  51. Ono A. HIV-1 assembly at the plasma membrane: gag trafficking and localization. Future Virol. 2009;4(3):241–57.PubMedView ArticleGoogle Scholar
  52. Zhou W, Resh MD. Differential membrane binding of the human immunodeficiency virus type 1 matrix protein. J Virol. 1996;70(12):8540–8.PubMedGoogle Scholar
  53. Dennin RH, Beyer A. Application of scanning electron microscopy (SEM) and microbead techniques to study the localization of p24 and p18 antigens of HIV-1 on the surface of HIV-1-infected H9-lymphocytes. J Microsc. 1991;164(Pt 1):53–60.PubMedView ArticleGoogle Scholar
  54. Haffar OK, Popov S, Dubrovsky L, Agostini I, Tang H, Pushkarsky T, et al. Two nuclear localization signals in the HIV-1 matrix protein regulate nuclear import of the HIV-1 pre-integration complex. J Mol Biol. 2000;299(2):359–68PubMedView ArticleGoogle Scholar
  55. Salgado GF, Vogel A, Marquant R, Feller SE, Bouaziz S, Alves ID. The role of membranes in the organization of HIV-1 Gag p6 and Vpr: p6 shows high affinity for membrane bilayers which substantially increases the interaction between p6 and Vpr. J Med Chem. 2009;52(22):7157–62PubMedView ArticleGoogle Scholar
  56. Ansari-Lari MA, Gibbs RA. Analysis of HIV type 1 reverse transcriptase expression in a human cell line. AIDS Res Hum Retroviruses. 1994;10(9):1117–24.PubMedView ArticleGoogle Scholar
  57. Levin A, Armon-Omer A, Rosenbluh J, Melamed-Book N, Graessmann A, Waigmann E, et al. Inhibition of HIV-1 integrase nuclear import and replication by a peptide bearing integrase putative nuclear localization signal. Retrovirology. 2009;6:112PubMedView ArticleGoogle Scholar
  58. Chen M, Elder RT, Yu M, O'Gorman MG, Selig L, Benarous R, et al. Mutational analysis of Vpr-induced G2 arrest, nuclear localization, and cell death in fission yeast. J Virol. 1999;73(4):3236–45PubMedGoogle Scholar
  59. Schubert U, Bour S, Ferrer-Montiel AV, Montal M, Maldarell F, Strebel K. The two biological activities of human immunodeficiency virus type 1 Vpu protein involve two separable structural domains. J Virol. 1996;70(2):809–19PubMedGoogle Scholar
  60. Wichroski MJ, Ichiyama K, Rana TM. Analysis of HIV-1 viral infectivity factor-mediated proteasome-dependent depletion of APOBEC3G: correlating function and subcellular localization. J Biol Chem. 2005;280(9):8387–96.PubMedView ArticleGoogle Scholar
  61. Fackler OT, Kienzle N, Kremmer E, Boese A, Schramm B, Klimkait T, et al. Association of human immunodeficiency virus Nef protein with actin is myristoylation dependent and influences its subcellular localization. Eur J Biochem. 1997;247(3):843–51PubMedView ArticleGoogle Scholar
  62. Boe SO, Bjorndal B, Rosok B, Szilvay AM, Kalland KH. Subcellular localization of human immunodeficiency virus type 1 RNAs, Rev, and the splicing factor SC-35. Virology. 1998;244(2):473–82PubMedView ArticleGoogle Scholar
  63. Yang Y, Ma J, Song Z, Wu M. HIV-1 TAT-mediated protein transduction and subcellular localization using novel expression vectors. FEBS Lett. 2002;532(1–2):36–44PubMedView ArticleGoogle Scholar
  64. Zhao Y, Yu M, Chen M, Elder RT, Yamamoto A, Cao J. Pleiotropic effects of HIV-1 protein R (Vpr) on morphogenesis and cell survival in fission yeast and antagonism by pentoxifylline. Virology. 1998;246(2):266–76PubMedView ArticleGoogle Scholar
  65. Maundrell K. nmt1 of fission yeast. A highly transcribed gene completely repressed by thiamine. J Biol Chem. 1990;265(19):10857–64.PubMedGoogle Scholar
  66. Mitchison DO. Physiological and cytological methods for Schizosaccharomyces pombe. Methods Cell Physiol. 1970;4:131–65.Google Scholar
  67. Hardy M, Rockenbauer A, Vasquez-Vivar J, Felix C, Lopez M, Srinivasan S, et al. Detection, characterization, and decay kinetics of ROS and thiyl adducts of mito-DEPMPO spin trap. Chem Res Toxicol. 2007;20(7):1053–60PubMedView ArticleGoogle Scholar
  68. Zhou Y, Ratner L. A novel inducible expression system to study transdominant mutants of HIV-1 Vpr. Virology. 2001;287(1):133–42.PubMedView ArticleGoogle Scholar
  69. Frei M. Cell viability and proliferation-trpan blue, in centrifugation. St. Louis: Sigma-Aldrich; 2001.Google Scholar
  70. Zhao, RY. Interactions of Vpr with host cellular proteins. Reactome. 2006;19. http://dx.doi.org/10.3180/REACT_6288.4.
  71. Sodroski J, Goh WC, Rosen C, Dayton A, Terwilliger E, Haseltine W. A second post-transcriptional trans-activator gene required for HTLV-III replication. Nature. 1986;321(6068):412–7PubMedView ArticleGoogle Scholar
  72. Pollard VW, Malim MH. The HIV-1 Rev protein. Annu Rev Microbiol. 1998;52:491–532.PubMedView ArticleGoogle Scholar
  73. Malim MH, Bohnlein S, Hauber J, Cullen BR. Functional dissection of the HIV-1 Rev trans-activator—derivation of a trans-dominant repressor of Rev function. Cell. 1989;58(1):205–14PubMedView ArticleGoogle Scholar
  74. Cochrane AW, Perkins A, Rosen CA. Identification of sequences important in the nucleolar localization of human immunodeficiency virus Rev: relevance of nucleolar localization to function. J Virol. 1990;64(2):881–5.PubMedGoogle Scholar
  75. Suhasini M, Reddy TR. Cellular proteins and HIV-1 Rev function. Curr HIV Res. 2009;7(1):91–100.PubMedView ArticleGoogle Scholar
  76. Malim MH, Hauber J, Le SY, Maizel JV, Cullen BR. The HIV-1 rev trans-activator acts through a structured target sequence to activate nuclear export of unspliced viral mRNA. Nature. 1989;338(6212):254–7PubMedView ArticleGoogle Scholar
  77. Stutz F, Neville M, Rosbash M. Identification of a novel nuclear pore-associated protein as a functional target of the HIV-1 Rev protein in yeast. Cell. 1995;82(3):495–506.PubMedView ArticleGoogle Scholar
  78. Levin A, Hayouka Z, Friedler A, Loyter A. Over-expression of the HIV-1 Rev promotes death of nondividing eukaryotic cells. Virus Genes. 2010;40(3):341–6.PubMedView ArticleGoogle Scholar
  79. Hockenbery DM, Oltvai ZN, Yin XM, Milliman CL, Korsmeyer SJ. Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell. 1993;75(2):241–51PubMedView ArticleGoogle Scholar
  80. Kane DJ, Sarafian TA, Anton R, Hahn H, Gralla EB, Valentine JS, et al. Bcl-2 inhibition of neural death: decreased generation of reactive oxygen species. Science. 1993;262(5137):1274–7PubMedView ArticleGoogle Scholar
  81. Fineberg K, Fineberg T, Graessmann A, Luedtke NW, Tor Y, Lixin R, et al. Inhibition of nuclear import mediated by the Rev-arginine rich motif by RNA molecules. Biochemistry. 2003;42(9):2625–33PubMedView ArticleGoogle Scholar
  82. No D, Yao TP, Evans RM. Ecdysone-inducible gene expression in mammalian cells and transgenic mice. Proc Natl Acad Sci USA. 1996;93(8):3346–51.PubMedView ArticleGoogle Scholar
  83. Thomas HE, Stunnenberg HG, Stewart AF. Heterodimerization of the Drosophila ecdysone receptor with retinoid X receptor and ultraspiracle. Nature. 1993;362(6419):471–5.PubMedView ArticleGoogle Scholar
  84. Basi G, Schmid E, Maundrell K. TATA box mutations in the Schizosaccharomyces pombe nmt1 promoter affect transcription efficiency but not the transcription start point or thiamine repressibility. Gene. 1993;123(1):131–6.PubMedView ArticleGoogle Scholar
  85. Lewis N, Williams J, Rekosh D, Hammarskjold ML. Identification of a cis-acting element in human immunodeficiency virus type 2 (HIV-2) that is responsive to the HIV-1 rev and human T-cell leukemia virus types I and II rex proteins. J Virol. 1990;64(4):1690–7PubMedGoogle Scholar
  86. Patki AH, Lederman MM. HIV-1 Tat protein and its inhibitor Ro 24-7429 inhibit lymphocyte proliferation and induce apoptosis in peripheral blood mononuclear cells from healthy donors. Cell Immunol. 1996;169(1):40–6.PubMedView ArticleGoogle Scholar
  87. BXT, Electro Cell Manipulator: ECM 600 protocol 0226. 2001.Google Scholar

Copyright

© Nkeze et al. 2015

Advertisement

Cell & Bioscience

ISSN: 2045-3701

Contact us